Loading organizations...
Loading organizations...
Developer of molecular pharmaceuticals for cancer treatments.
GenFleet Therapeutics has raised $96.0M across 2 funding rounds.
GenFleet Therapeutics has raised $96.0M in total across 2 funding rounds.
GenFleet Therapeutics has raised $96.0M in total across 2 funding rounds.
GenFleet Therapeutics's investors include Zeng Zhiqiang, Baidu Ventures, CDH Investments, Cherami Investment Group, Dyee Capital, HM Capital, Lake Bleu Capital, Panlin Capital, Qiaojing Eastern Investment, Shanjin Asset, Suxin Venture Capital, Ally Bridge Group.
GenFleet Therapeutics has raised $96.0M across 2 funding rounds. Most recently, it raised $78.5M Series C in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2022 | $78.5M Series C | Zeng Zhiqiang | Baidu Ventures, CDH Investments, Cherami Investment Group, Dyee Capital, HM Capital, Lake Bleu Capital, Panlin Capital, Qiaojing Eastern Investment, Shanjin Asset, Suxin Venture Capital |
| Dec 30, 2018 | $17.5M Series A | Ally Bridge Group | CSPC Pharma, Hidragon Capital, Sinopharm Capital, TF Capital |